$ALAB

Astera Labs (ALAB) Q3 2026 Earnings Call Transcript

Astera Labs (ALAB) reported Q3 2026 revenue of $584.9M, up 49% sequentially and 154% YoY. Growth was driven by the Scorpio X-Series, which surpassed P-Series in revenue. The company launched new products, including Aries 7 and Leo 2, and expanded its customer base. Management expects continued growth and increased design wins, with AI infrastructure demand strengthening.

Original reporting
Published Nov 4, 2026, 3:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 3:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Astera Labs (ALAB) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ALABBullishMed
01

Why it matters

The call combines reported Q3 results with product and customer traction updates, which can shift investor expectations for utilization, design-win conversion, and the timing of next-generation platform revenue.

02

Market read

Company-specific revenue growth and detailed traction updates can influence near-term positioning in AI infrastructure supply-chain trades.

03

What to watch

Key risks are whether preproduction volumes to new customers in the current quarter materialize as expected and how quickly Leo and Orion ramp into meaningful revenue beyond early interest.

Relevance 8/10Novelty 7/10Timing: post-market earnings call transcript, positioning for Q4 expectations

Background

Astera Labs’ Q3 2026 earnings call focuses on AI fabric (Scorpio X-Series, P-Series) and signal conditioning, plus new connectivity and memory-controller product launches.

Company-level read

Ticker impact

$ALABBullishHigh confidence
Context

Astera Labs reports Q3 2026 record revenue of $584.9M and details Scorpio X-Series ramp, new product launches, and Q4 guidance.

Expected impact

Likely upward bias as investors price in continued Scorpio ramp, expanding design-ins, and Q4 guidance confidence.

Evidence & confidence

The transcript provides company-specific performance metrics (revenue growth) plus forward-looking shipment and qualification timelines that can directly affect near-term expectations.

Market effects

Reinforces demand narrative for AI fabric and signal conditioning amid constrained wafer, power, and memory supply, emphasizing utilization and inference workloads.

No clear regional-specific impact stated.

Highlights hyperscaler capex and AI infrastructure buildout dynamics that can influence global supply-chain sentiment.

Counterpoint

Despite strong growth, the transcript emphasizes tight constraints (wafer capacity, grid power, memory supply), which could cap near-term revenue conversion or delay shipments.

Key entities

  • Astera Labs

    AI fabric and signal conditioning provider reporting Q3 2026 results and Q4 guidance on an earnings call.

  • Scorpio X-Series

    High-volume AI fabric product family highlighted as driving record Q3 revenue and annualized run-rate.

  • Leo memory controllers

    Smart memory controllers for AI workloads, with qualification and ramp expectations discussed.

  • Orion rack-scale architecture

    Compute-agnostic rack-scale architecture generating early customer interest with initial shipments expected in 2027.

Related articles

$ALABHighAI 8/10

Northland upgrades Astera Labs stock rating on strong quarter

Northland upgraded Astera Labs (ALAB) to Outperform with a $315 price target, citing strong Q3 results and raised guidance. The Scorpio switch family exceeded $1B annual run rate, driving 98% revenue growth over the last year. Despite a 21% stock drop, ALAB trades above Fair Value. Other analysts lowered price targets due to valuation concerns.

$ALABMedAI 8/10

Needham cuts Astera Labs stock price target on AI sector valuation

Needham reduced its price target for Astera Labs (ALAB) to $300 from $425, citing AI sector valuation pressures, despite raising its estimates. ALAB's stock fell 21% in a week and is deemed overvalued by InvestingPro's Fair Value calculation. The company reported strong Q3 2026 results, with revenue up 98% YoY to $1.2B, and raised guidance. UBS also cut its target to $290 but raised revenue and earnings forecasts through 2028.

$ALABHighAI 8/10

Astera Labs Stock Rises After Revenue Jumps 154%

Astera Labs (ALAB) reported Q3 revenue of $584.9M, up 154% YoY, beating estimates. Non-GAAP EPS was $1.32 vs. $1.19 expected. Non-GAAP operating margin widened to 44.7%, but gross margin slipped to 72.4%. Q4 guidance: revenue $730M-$750M, non-GAAP EPS $1.62-$1.66. Inventory rose to $200.9M.

$ALABMed

UBS lowers Astera Labs stock price target on valuation concerns

UBS lowered its price target on Astera Labs (ALAB) to $290 from $300, citing valuation concerns and compressed semiconductor sector multiples. The stock has fallen 21% in the past week. UBS raised revenue and earnings estimates for 2026-2028, forecasting $7.82 EPS by 2028. Astera Labs reported strong Q3 2026 results, with revenue up 154% year-over-year and adjusted earnings of $1.32 per share, beating estimates.